Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov site’s displayed release/version from **v3.5.2** to **v3.5.3** without changing any study content.
    Difference
    0.0%
    Check dated 2026-04-24T06:18:02.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:38:43.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-19T06:30:54.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    - Revision tag updated from v3.4.2 to v3.4.3 on the page. This appears to be a minor maintenance update and does not affect the study information presented.
    Difference
    0.0%
    Check dated 2026-03-12T02:33:06.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; deleted the government funding lapse notice and Revision: v3.4.1, representing administrative site updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:22:23.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A government-funding notice was added about the NIH Clinical Center's status, and the page revision version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:29:46.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.